title: Anti-plasmodial activity of aroylhydrazone and thiosemicarbazone iron chelators: effect on erythrocyte membrane integrity, parasite development and the intracellular labile iron pool.
abstract: Iron chelators inhibit the growth of the malaria parasite, Plasmodium falciparum, in culture and in animal and human studies. We previously reported the anti-plasmodial activity of the chelators, 2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone (311), 2-hydroxy-1-naphthylaldehyde 4-methyl-3-thiosemicarbazone (N4mT), and 2-hydroxy-1-naphthylaldehyde 4-phenyl-3-thiosemicarbazone (N4pT). In fact, these ligands showed greater growth inhibition of chloroquine-sensitive (3D7) and chloroquine-resistant (7G8) strains of P. falciparum in culture compared to desferrioxamine (DFO). The present study examined the effects of 311, N4mT and N4pT on erythrocyte membrane integrity and asexual parasite development. While the characteristic biconcave disk shape of the erythrocytes was unaffected, the chelators caused very slight hemolysis at IC50 values that inhibited parasite growth. The chelators 311, N4mT and N4pT affected all stages of the intra-erythrocytic development cycle (IDC) of P. falciparum in culture. However, while these ligands primarily affected the ring-stage, DFO inhibited primarily trophozoite and schizont-stages. Ring, trophozoite and schizont-stages of the IDC were inhibited by significantly lower concentrations of 311, N4mT, and N4pT (IC50=4.45±1.70, 10.30±4.40, and 3.64±2.00μM, respectively) than DFO (IC50=23.43±3.40μM). Complexation of 311, N4mT and N4pT with iron reduced their anti-plasmodial activity. Estimation of the intracellular labile iron pool (LIP) in erythrocytes showed that the chelation efficacy of 311, N4mT and N4pT corresponded to their anti-plasmodial activities, suggesting that the LIP may be a potential source of non-heme iron for parasite metabolism within the erythrocyte. This study has implications for malaria chemotherapy that specifically disrupts parasite iron utilization.
authors.affiliation: Department of Physiology and Biophysics, Howard University College of Medicine, Washington, DC 20059, USA. Electronic address: awalcourt@howard.edu.
authors.forename: Asikiya
authors.initials: A
authors.lastname: Walcourt
authors.forename: Joseph
authors.initials: J
authors.lastname: Kurantsin-Mills
authors.forename: John
authors.initials: J
authors.lastname: Kwagyan
authors.forename: Babafemi B
authors.initials: BB
authors.lastname: Adenuga
authors.forename: Danuta S
authors.initials: DS
authors.lastname: Kalinowski
authors.forename: David B
authors.initials: DB
authors.lastname: Lovejoy
authors.forename: Darius J R
authors.initials: DJ
authors.lastname: Lane
authors.forename: Des R
authors.initials: DR
authors.lastname: Richardson
mesh_terms: D000962:Antimalarials / Q000737:chemistry / Q000494:pharmacology; D004910:Erythrocyte Membrane / Q000737:chemistry / Q000378:metabolism*; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D006835:Hydrazones / Q000737:chemistry / Q000494:pharmacology; D007502:Iron Chelating Agents / Q000737:chemistry / Q000494:pharmacology; D010963:Plasmodium falciparum / Q000378:metabolism*; D012663:Semicarbazides / Q000737:chemistry / Q000494:pharmacology
chemical_list: D000962:Antimalarials; D006835:Hydrazones; D007502:Iron Chelating Agents; D012663:Semicarbazides; C005151:thiosemicarbazide
keywords: Aroylhydrazone; Erythrocytes; Iron chelator; Plasmodium falciparum; Thiosemicarbazone
references.citation: J Lab Clin Med. 1998 Oct;132(4):351-2
references.pmid: 9794707
references.citation: J Lab Clin Med. 1996 Jun;127(6):574-82
references.pmid: 8648262
references.citation: PLoS Comput Biol. 2009 Apr;5(4):e1000339
references.pmid: 19343220
references.citation: Anal Biochem. 1997 May 15;248(1):31-40
references.pmid: 9177722
references.citation: J Biol Chem. 2003 Nov 21;278(47):46403-13
references.pmid: 12963736
references.citation: Annu Rev Microbiol. 1997;51:97-123
references.pmid: 9343345
references.citation: Biochim Biophys Acta. 1987 May 12;899(1):93-103
references.pmid: 3567196
references.citation: Science. 1976 Aug 20;193(4254):673-5
references.pmid: 781840
references.citation: J Biomech. 1997 Jan;30(1):35-40
references.pmid: 8970922
references.citation: Parasitol Res. 2007 Sep;101(4):835-42
references.pmid: 17549517
references.citation: Pharmacol Ther. 1999 Jan;81(1):53-75
references.pmid: 10051178
references.citation: Biochim Biophys Acta. 1999 Feb 2;1426(3):475-82
references.pmid: 10076064
references.citation: Methods Enzymol. 1988;158:110-4
references.pmid: 3374366
references.citation: J Biol Chem. 1999 May 7;274(19):13375-83
references.pmid: 10224100
references.citation: Blood. 2002 Jul 15;100(2):666-76
references.pmid: 12091363
references.citation: Drug Discov Today. 2001 Nov 15;6(22):1151
references.pmid: 11700215
references.citation: Clin Cancer Res. 2003 Jan;9(1):402-14
references.pmid: 12538494
references.citation: Blood. 1995 Dec 1;86(11):4295-306
references.pmid: 7492790
references.citation: Blood. 1977 Sep;50(3):433-9
references.pmid: 328083
references.citation: Antimicrob Agents Chemother. 1997 Sep;41(9):2061-3
references.pmid: 9303419
references.citation: J Biol Chem. 2013 Jun 14;288(24):17791-802
references.pmid: 23640898
references.citation: J Cell Biol. 1976 Jul;70(1):247-51
references.pmid: 932100
references.citation: Am J Hematol. 1991 Jul;37(3):206-8
references.pmid: 1858775
references.citation: Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9280-4
references.pmid: 8415692
references.citation: Trends Parasitol. 2007 Oct;23(10):502-9
references.pmid: 17888738
references.citation: Antimicrob Agents Chemother. 2002 Jan;46(1):225-8
references.pmid: 11751139
references.citation: Pharmacol Rev. 2005 Dec;57(4):547-83
references.pmid: 16382108
references.citation: Annu Rev Microbiol. 2009;63:195-221
references.pmid: 19575563
references.citation: Br J Pharmacol. 2003 Mar;138(5):819-30
references.pmid: 12642383
references.citation: Mol Biochem Parasitol. 1999 Jun 25;101(1-2):43-59
references.pmid: 10413042
references.citation: Biochem J. 2002 Jul 15;365(Pt 2):343-7
references.pmid: 12033986
references.citation: Parasitology. 1994 Dec;109 ( Pt 5):539-49
references.pmid: 7831089
references.citation: Malar J. 2006 Jul 31;5:64
references.pmid: 16879740
references.citation: Biochem Pharmacol. 1979 Mar 1;28(5):613-20
references.pmid: 444248
references.citation: Cell. 2006 Feb 24;124(4):755-66
references.pmid: 16497586
references.citation: PLoS One. 2013;8(3):e60150
references.pmid: 23555907
references.citation: Antimicrob Agents Chemother. 2002 May;46(5):1441-6
references.pmid: 11959580
references.citation: Annu Rev Biochem. 1998;67:71-98
references.pmid: 9759483
references.citation: J Biol Chem. 2012 Nov 2;287(45):37793-807
references.pmid: 22992734
references.citation: J Parasitol. 1979 Jun;65(3):418-20
references.pmid: 383936
references.citation: Nature. 2005 Mar 10;434(7030):214-7
references.pmid: 15759000
references.citation: Nature. 2000 Aug 31;406(6799):1001-5
references.pmid: 10984055
references.citation: Am J Physiol. 1998 Jun;274(6):G1031-7
references.pmid: 9696702
references.citation: Exp Parasitol. 1985 Oct;60(2):171-4
references.pmid: 4029347
references.citation: Clin Microbiol Rev. 2011 Apr;24(2):377-410
references.pmid: 21482730
references.citation: Antimicrob Agents Chemother. 2004 Oct;48(10):4067-71
references.pmid: 15388483
references.citation: Int J Parasitol. 2009 Jan;39(1):91-6
references.pmid: 18952091
references.citation: Mol Pharmacol. 2012 Jul;82(1):105-14
references.pmid: 22508546
references.citation: Int J Biochem Cell Biol. 2004 Mar;36(3):401-7
references.pmid: 14687919
references.citation: Blood. 2003 Jul 1;102(1):357-64
references.pmid: 12623854
references.citation: Exp Parasitol. 1993 Nov;77(3):261-72
references.pmid: 8224082
references.citation: J Biol Chem. 1995 Oct 13;270(41):24209-15
references.pmid: 7592626